Works matching DE "APOMORPHINE"

Results: 611

Effectiveness of Continuous Dopaminergic Therapies in Parkinson's Disease: A Review of L-DOPA Pharmacokinetics/Pharmacodynamics.

Published in:

Journal of Parkinson's Disease, 2024, v. 14, n. 5, p. 925, doi. 10.3233/JPD-230372

By:

Demailly, Alexandre;
Moreau, Caroline;
Devos, David

Publication type:

Article

Apomorphine Sublingual Film Compared with Subcutaneous Apomorphine for OFF Episodes in Parkinson's Disease: An Open-Label, Randomized, Crossover Study.

Published in:

Journal of Parkinson's Disease, 2023, v. 13, n. 8, p. 1329, doi. 10.3233/JPD-230072

By:

Stocchi, Fabrizio;
Rascol, Olivier;
Poewe, Werner;
Chaudhuri, K. Ray;
Kassubek, Jan;
Lopez Manzanares, Lydia;
Zhang, Yi;
Bowling, Alyssa;
Pappert, Eric;
Wu, Stacy

Publication type:

Article

Drugs to the Rescue: Comparison of On-Demand Therapies for OFF Symptoms in Parkinson's Disease.

Published in:

Journal of Parkinson's Disease, 2023, v. 13, n. 4, p. 441, doi. 10.3233/JPD-230055

By:

Martinez-Nunez, Alfonso E.;
LeWitt, Peter A.

Publication type:

Article

Dose Optimization of Apomorphine Sublingual Film for OFF Episodes in Parkinson's Disease: Is the Prophylactic Use of an Antiemetic Necessary?

Published in:

Journal of Parkinson's Disease, 2023, v. 13, n. 3, p. 403, doi. 10.3233/JPD-223537

By:

Hauser, Robert A.;
Ondo, William G.;
Zhang, Yi;
Bowling, Alyssa;
Navia, Bradford;
Pappert, Eric;
Isaacson, Stuart H.

Publication type:

Article

Evaluating the Efficacy of Nocturnal Continuous Subcutaneous Apomorphine Infusion in Sleep Disorders in Advanced Parkinson's Disease: The APO-NIGHT Study.

Published in:

Journal of Parkinson's Disease, 2016, v. 6, n. 4, p. 787, doi. 10.3233/JPD-160886

By:

Fernández-Pajarín, Gustavo;
Sesar, Ángel;
Ares, Begoña;
Castro, Alfonso

Publication type:

Article

Inhaled Apomorphine in Patients with 'on-off' Fluctuations: A Randomized, Double-blind, Placebo-controlled, Clinic and Home Based, Parallel-group Study.

Published in:

Journal of Parkinson's Disease, 2013, v. 3, n. 1, p. 31, doi. 10.3233/jpd-120142

By:

Grosset, Katherine A.;
Malek, Naveed;
Morgan, Frazer;
Grosset, Donald G.

Publication type:

Article

A Highly Potent Apomorphine Derivative Enhancing Neurite Outgrowth via Nrf2 Activation.

Published in:

Antioxidants, 2025, v. 14, n. 5, p. 537, doi. 10.3390/antiox14050537

By:

Ishima, Tamaki;
Osaka, Hitoshi;
Nagai, Ryozo;
Aizawa, Kenichi

Publication type:

Article

The Great Indian Apomorphine Story: Challenges and Its Usage in Parkinson's Disease in the Indian Context.

Published in:

2021

By:

Dhamija, Rajinder;
Garg, Divyani;
Dhamija, Rajinder K

Publication type:

journal article

Chromosome painting in Tragulidae facilitates the reconstruction of Ruminantia ancestral karyotype.

Published in:

Chromosome Research, 2011, v. 19, n. 4, p. 531, doi. 10.1007/s10577-011-9201-z

By:

Kulemzina, Anastasia;
Yang, Fengtang;
Trifonov, Vladimir;
Ryder, Oliver;
Ferguson-Smith, Malcolm;
Graphodatsky, Alexander

Publication type:

Article

Behavioural profile of Wistar rats with unilateral striatal lesion by quinolinic acid (animal model of Huntington disease) post-injection of apomorphine and exposure to static magnetic field.

Published in:

Experimental Brain Research, 2015, v. 233, n. 5, p. 1455, doi. 10.1007/s00221-015-4219-7

By:

Giorgetto, Carolina;
Silva, Elaine;
Kitabatake, Takae;
Bertolino, Guilherme;
de Araujo, João

Publication type:

Article

Task Specific Tremor in Parkinson's Disease Responds to Apomorphine.

Published in:

Tremor & Other Hyperkinetic Movements, 2023, v. 13, p. 1, doi. 10.5334/tohm.764

By:

Ondo, William G.;
Koneru, Vindhya;
Arif, Chia

Publication type:

Article

Necrotic Ulcers Secondary to Apomorphine Infusion.

Published in:

Tremor & Other Hyperkinetic Movements, 2021, v. 11, p. 1, doi. 10.5334/tohm.648

By:

LLAMAS-OSORIO, YUDY;
MCLOUGHLIN, CAITRIONA;
MAGUIRE, MICHAEL;
LYNCH, TIM

Publication type:

Article

Exploring promising minor natural phenolic compounds in neuroprotection‐related preclinical models.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2024, v. 134, n. 6, p. 770, doi. 10.1111/bcpt.14006

By:

Moreira Vasconcelos, Carlos Franciney;
Neugebauer, Agnieszka Zofia;
Basto Souza, Ricardo

Publication type:

Article

Intravenous Administration of Apomorphine Does NOT Induce Long QT Syndrome: Experimental Evidence from In Vivo Canine Models.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2015, v. 116, n. 6, p. 468, doi. 10.1111/bcpt.12343

By:

Watanabe, Yudai;
Nakamura, Yuji;
Cao, Xin;
Ohara, Hiroshi;
Yamazaki, Yukiko;
Murayama, Norie;
Sugiyama, Yosuke;
Izumi‐Nakaseko, Hiroko;
Ando, Kentaro;
Yamazaki, Hiroshi;
Sugiyama, Atsushi

Publication type:

Article

Correction: Apomorphine-induced pathway perturbation in MPP<sup>+</sup>-treated SH-SY5Y cells.

Published in:: 2017
Publication type:: Correction Notice

Apomorphine-induced pathway perturbation in MPP+-treated SHSY5Y cells.

Published in:

AIMS Molecular Science, 2017, v. 4, n. 3, p. 271, doi. 10.3934/molsci.2017.3.271

By:

Jin Hwan Do

Publication type:

Article

Sublingual apomorphine therapy as an alternative to complex continuous infusion pumps in advanced Parkinson's disease treatment: a district nurse-led intervention.

Published in:

British Journal of Community Nursing, 2022, v. 27, n. 7, p. 328, doi. 10.12968/bjcn.2022.27.7.328

By:

Macaulay, Karis

Publication type:

Article

The importance of community nurses in supporting Parkinson's patients on complex therapies.

Published in:

British Journal of Community Nursing, 2022, v. 27, n. 2, p. 90, doi. 10.12968/bjcn.2022.27.2.90

By:

Peel, Charlie;
Thomas, Sue

Publication type:

Article

MiRNA‐100 ameliorates diabetes mellitus‐induced erectile dysfunction by modulating autophagy, anti‐inflammatory, and antifibrotic effects.

Published in:

Andrology, 2024, v. 12, n. 6, p. 1280, doi. 10.1111/andr.13586

By:

Li, Beining;
Hu, Peng;
Liu, Kang;
Xu, Wenchao;
Wang, Jiaxin;
Li, Qinyu;
Chen, Bingliang;
Deng, Yuxuan;
Han, Chenglin;
Sun, Taotao;
Liu, Xinqi;
Li, Mingchao;
Wang, Tao;
Liu, Jihong;
Lin, Huang;
Rao, Ke

Publication type:

Article

Paeonol ameliorates diabetic erectile dysfunction by inhibiting HMGB1/RAGE/NF-κB pathway.

Published in:

Andrology, 2023, v. 11, n. 2, p. 344, doi. 10.1111/andr.13203

By:

Taotao Sun;
Wenchao Xu;
Jiaxin Wang;
Jingyu Song;
Tao Wang;
Shaogang Wang;
Kang Liu;
Jihong Liu

Publication type:

Article

Berberine ameliorates erectile dysfunction in rats with streptozotocin‐induced diabetes mellitus through the attenuation of apoptosis by inhibiting the SPHK1/S1P/S1PR2 and MAPK pathways.

Published in:

Andrology, 2022, v. 10, n. 2, p. 404, doi. 10.1111/andr.13119

By:

Liu, Kang;
Sun, Taotao;
Luan, Yang;
Chen, Yinwei;
Song, Jingyu;
Ling, Le;
Yuan, Penghui;
Li, Rui;
Cui, Kai;
Ruan, Yajun;
Lan, Ruzhu;
Wang, Tao;
Wang, Shaogang;
Liu, Jihong;
Rao, Ke

Publication type:

Article

JTE‐013 supplementation improves erectile dysfunction in rats with streptozotocin‐induced type Ⅰ diabetes through the inhibition of the rho‐kinase pathway, fibrosis, and apoptosis.

Published in:

Andrology, 2020, v. 8, n. 2, p. 497, doi. 10.1111/andr.12716

By:

Liu, K.;
Cui, K.;
Feng, H.;
Li, R.;
Lin, H.;
Chen, Y.;
Zhang, Y.;
Chen, Z.;
Yuan, H.;
Li, M.;
Wang, T.;
Lan, R.;
Liu, J.;
Rao, K.;
Wen, B.

Publication type:

Article

Contribution of the GABAergic System to Non-Motor Manifestations in Premotor and Early Stages of Parkinson's Disease.

Published in:

Frontiers in Pharmacology, 2019, v. 10, p. 1, doi. 10.3389/fphar.2019.01294

By:

Murueta-Goyena, Ane;
Andikoetxea, Ane;
Gómez-Esteban, Juan Carlos;
Gabilondo, Iñigo

Publication type:

Article

Turmeric active substance, curcumin, enhanced apomorphine-induced yawning in rats.

Published in:

Avicenna Journal of Phytomedicine, 2013, v. 3, n. 3, p. 231

By:

Tamaddonfard, Esmaeal

Publication type:

Article

The effect of red grape juice and exercise, and their combination on parkinson's disease in rats.

Published in:

Avicenna Journal of Phytomedicine, 2012, v. 2, n. 2, p. 90

By:

Eshraghi-Jazi, Fatemeh;
Alaei, Hojjatallah;
Azizi-Malekabadi, Hamid;
Gharavi-Naini, Mahin;
Pilehvarian, Aliasghar;
ciahmard, Zahra

Publication type:

Article

Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.

Published in:

Drugs, 2016, v. 76, n. 7, p. 759, doi. 10.1007/s40265-016-0566-3

By:

Vijayakumar, Dhanya;
Jankovic, Joseph

Publication type:

Article

A new method for selective measurement of joint movement in hand tremor in Parkinson's disease patients.

Published in:

Journal of Medical Engineering & Technology, 2007, v. 31, n. 4, p. 305, doi. 10.1080/03091900600992064

By:

Rozman, J.;
Bartolić, A.;
Ribarič, S.

Publication type:

Article

ALTITUDINAL VARIABILITY IN WING PATTERNS OF PHYLLONORYCTER SALICTELLA (ZELLER, 1846) (LEPIDOPTERA: GRACILLARIIDAE).

Published in:

Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, 2017, v. 65, n. 3, p. 833, doi. 10.11118/actaun201765030833

By:

Gregor, František;
Šefrová, Hana;
Laštůvka, Zdeněk

Publication type:

Article

Erich Harnack (1852–1915) and a Short History of Apomorphine.

Published in:

European Neurology, 2013, v. 69, n. 6, p. 321, doi. 10.1159/000346762

By:

Taba, Pille;
Lees, andrew;
Stern, Gerald

Publication type:

Article

Major eosinophilia induced by subcutaneous apomorphine infusion: four cases.

Published in:

European Journal of Neurology, 2013, v. 20, n. 7, p. e92, doi. 10.1111/ene.12149

By:

Moisset, X.;
Castrioto, A.;
Vitello, N.;
Lemal, R.;
Fraix, V.;
Krack, P.;
Durif, F.

Publication type:

Article

Motor features and response to oral levodopa in patients with Parkinson's disease under continuous dopaminergic infusion or deep brain stimulation.

Published in:

European Journal of Neurology, 2012, v. 19, n. 1, p. 76, doi. 10.1111/j.1468-1331.2011.03437.x

By:

Elia, A. E.;
Dollenz, C.;
Soliveri, P.;
Albanese, A.

Publication type:

Article

Postural stability of Parkinson's disease patients is improved by decreasing rigidity.

Published in:

European Journal of Neurology, 2005, v. 12, n. 2, p. 156, doi. 10.1111/j.1468-1331.2004.00942.x

By:

Bartolić, A.;
Pirtošek, Z.;
Rozman, J.;
Ribarič, S.

Publication type:

Article

The effects of a dopamine agonist (apomorphine) on experimental and spontaneous pain in patients with chronic radicular pain: A randomized, double-blind, placebo-controlled, cross-over study.

Published in:

PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0195287

By:

Haddad, May;
Pud, Dorit;
Treister, Roi;
Suzan, Erica;
Eisenberg, Elon

Publication type:

Article

Early commercial assessments: An innovative tactic for small biotechs.

Published in:

Journal of Commercial Biotechnology, 2015, v. 21, n. 2, p. 43, doi. 10.5912/jcb700

By:

Giovinazzo, Anthony

Publication type:

Article

Creating systemic oral transmucosal drug delivery strategies: Case study of APL-130277.

Published in:

Journal of Commercial Biotechnology, 2012, v. 18, n. 3, p. 33, doi. 10.5912/jcb556

By:

Giovinazzo, Anthony;
Bryson, Nathan;
Tankosic, Timothy

Publication type:

Article

Apomorphine Reduces A53T α-Synuclein-Induced Microglial Reactivity Through Activation of NRF2 Signalling Pathway.

Published in:

Cellular & Molecular Neurobiology, 2022, v. 42, n. 8, p. 2673, doi. 10.1007/s10571-021-01131-1

By:

Heurtaux, Tony;
Kirchmeyer, Melanie;
Koncina, Eric;
Felten, Paul;
Richart, Lorraine;
Uriarte Huarte, Oihane;
Schohn, Herve;
Mittelbronn, Michel

Publication type:

Article

Ventral Midbrain NMDA Receptor Blockade: From Enhanced Reward and Dopamine Inactivation.

Published in:

Frontiers in Behavioral Neuroscience, 2016, p. 1, doi. 10.3389/fnbeh.2016.00161

By:

Hernandez, Giovanni;
Cossette, Marie-Pierre;
Shizgal, Peter;
Rompré, Pierre-Paul;
Izquierdo, Alicia;
Akiko Shimamoto

Publication type:

Article

Maternal care affects the phenotype of a rat model for schizophrenia.

Published in:

Frontiers in Behavioral Neuroscience, 2014, v. 8, p. 1, doi. 10.3389/fnbeh.2014.00268

By:

van Vugt, Ruben W. M.;
Meyer, Francisca;
van Hulten, Josephus A.;
Vernooij, Jeroen;
Cools, Alexander R.;
Verheij, Michel M. M.;
Martens, Gerard J. M.

Publication type:

Article

Maternal care affects the phenotype of a rat model for schizophrenia.

Published in:

Frontiers in Behavioral Neuroscience, 2014, v. 8, p. 1, doi. 10.3389/fnbeh.2014.00268

By:

van Vugt, Ruben W. M.;
Meyer, Francisca;
van Hulten, Josephus A.;
Vernooij, Jeroen;
Cools, Alexander R.;
Verheij, Michel M. M.;
Martens, Gerard J. M.

Publication type:

Article

The pragmatic use of apomorphine at the end of life.

Published in:

Palliative Medicine, 2009, v. 23, n. 8, p. 777, doi. 10.1177/0269216309106979

By:

Dewhurst, F.;
Lee, M.;
Wood, B.

Publication type:

Article

Dopamine agonists in the treatment of Parkinson's disease: the show must go on.

Published in:

Journal of Neural Transmission, 2024, v. 131, n. 12, p. 1471, doi. 10.1007/s00702-024-02825-8

By:

Jost, Wolfgang H.

Publication type:

Article

Monotherapy with infusion therapies – useful or not?

Published in:

Journal of Neural Transmission, 2024, v. 131, n. 11, p. 1341, doi. 10.1007/s00702-024-02801-2

By:

Rožanković, Petra Bago;
Johansson, Anders;
Péter, Klivényi;
Milanov, Ivan;
Odin, Per

Publication type:

Article

Sublingual apomorphine in the treatment of Parkinson's disease.

Published in:

Journal of Neural Transmission, 2024, v. 131, n. 10, p. 1209, doi. 10.1007/s00702-024-02777-z

By:

Kassubek, Jan;
Jost, Wolfgang H.;
Schwarz, Johannes

Publication type:

Article

Correction to: Role of dopamine agonists in Parkinson's disease therapy.

Published in:

2024

By:

Woitalla, D.;
Buhmann, C.;
Hilker-Roggendorf, R.;
Höglinger, G.;
Koschel, J.;
Müller, T.;
Weise, D.

Publication type:

Correction Notice

Home initiation of apomorphine infusion: lessons from the COVID-19 pandemic and implications for current clinical practice.

Published in:

Journal of Neural Transmission, 2023, v. 130, n. 11, p. 1485, doi. 10.1007/s00702-023-02710-w

By:

Kobylecki, Christopher;
Partington-Smith, Lucy

Publication type:

Article

Practical use of apomorphine infusion in Parkinson's disease: lessons from the TOLEDO study and clinical experience.

Published in:

Journal of Neural Transmission, 2023, v. 130, n. 11, p. 1475, doi. 10.1007/s00702-023-02686-7

By:

Henriksen, Tove;
Katzenschlager, Regina;
Bhidayasiri, Roongroj;
Staines, Harry;
Lockhart, Donna;
Lees, Andrew

Publication type:

Article

Adopting the Rumsfeld approach to understanding the action of levodopa and apomorphine in Parkinson's disease.

Published in:

Journal of Neural Transmission, 2023, v. 130, n. 11, p. 1337, doi. 10.1007/s00702-023-02655-0

By:

Jenner, P.;
Falup-Pecurariu, C.;
Leta, V.;
Verin, M.;
Auffret, M.;
Bhidayasiri, Roongroj;
Weiss, D.;
Borovečki, F.;
Jost, W. H.

Publication type:

Article

Dynamics of device-based treatments for Parkinson's disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa–carbidopa intestinal gel, and deep brain stimulation.

Published in:

Journal of Neural Transmission, 2019, v. 126, n. 7, p. 879, doi. 10.1007/s00702-019-02034-8

By:

Richter, Daniel;
Bartig, Dirk;
Jost, Wolfgang;
Jörges, Christoph;
Stumpe, Britta;
Gold, Ralf;
Krogias, Christos;
Tönges, Lars

Publication type:

Article

Apomorphine and levodopa infusion for motor fluctuations and dyskinesia in advanced Parkinson disease.

Published in:

Journal of Neural Transmission, 2018, v. 125, n. 8, p. 1131, doi. 10.1007/s00702-018-1906-0

By:

Antonini, Angelo;
Nitu, Bianca

Publication type:

Article

Erratum to: Treatment of camptocormia with continuous subcutaneous infusions of apomorphine: 1-year prospective pilot study.

Published in:

2015

By:

Mensikova, Katerina;
Kaiserova, Michaela;
Vastik, Miroslav;
Kurcova, Sandra;
Kanovsky, Petr

Publication type:

Erratum